| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |